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OBJECTIVE: The purpose of this study was to evaluate the association between the presence of clinical symptoms
of peripheral artery disease and severe renal artery stenosis in patients referred for renal angiography.
METHOD: We included 82 patients with clinical suspicion of renovascular hypertension and performed an
imaging investigation (renal Doppler ultrasound and/or renal scintigraphy) for possible renal artery stenosis.
All patients underwent renal arteriography and were examined for peripheral artery disease based on the
presence of intermittent claudication and ankle-brachial index test results. Severe renal artery stenosis was
defined as a lesion causing 70% obstruction.
RESULTS: Severe renal artery stenosis was present in 32 of 82 (39%) patients. Patients with severe renal artery
stenosis were older (63±12 vs 56±12 years, p=0.006), had more intermittent claudication (55 vs 45%, p=0.027),
and had a greater prevalence of an ankle-brachial index o0.9 (44% vs 20%, p=0.021) than patients without
severe renal artery stenosis. Multivariate logistic regression analysis showed that the presence of intermittent
claudication was independently associated with renal artery stenosis X70% (OR: 3.33; 95% CI 1.03–10.82,
p=0.04), unlike the ankle-brachial index, which showed no association (OR: 1.44; 95% CI 0.37–5.66, p=0.60).
CONCLUSION: Intermittent claudication is independently associated with severe renal artery stenosis (X70%) in
patients clinically suspected of having renovascular hypertension.
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’ INTRODUCTION
Atherosclerotic renal stenosis is a significant cause of sec-
ondary arterial hypertension and is strongly associated with
cardiovascular events (1,2), independent of the degree of hyper-
tension (3,4). Previous studies have shown the coexistence
of renal artery stenosis (RAS) with atherosclerosis at other
vascular sites (5-7) and high blood pressure is linked to an
increased incidence of peripheral artery disease (PAD) (8).
Most patients with PAD have no symptoms but do expe-
rience intermittent claudication (IC), the main symptom
of PAD, which is frequently underdiagnosed (2) in patients
with hypertension. During the clinical investigation, the
presence of symptoms suggestive of PAD should be further
investigated using the ankle-brachial index (ABI) test. This
test, besides being an important diagnostic tool, provides
significant information about the presence of subclinical
atherosclerosis (2) and the increased risk of cardiovascular
morbidity and mortality (3). Furthermore, in the presence of
vascular risk factors such as hypertension, the detection
of asymptomatic PAD may represent the need for a change
from primary to secondary prevention, resulting in more
rigorous treatment strategies.
Evidence has shown that RAS is a predictor of coronary
artery disease (CAD) and a marker of diffuse atherosclerosis
(9-11). In a previous study, the authors identified predictors
of serious CAD (X70%) in patients with clinical suspicion
of severe RAS (X70%). Severe RAS is a strong predictor of
serious CAD independent of angina, and dual investigation
should be considered in patients referred for renal angio-
graphy (9). The purpose of our study was to determine
whether IC could be a clinical predictor of severe RAS inDOI: 10.6061/clinics/2017(07)04
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hypertensive patients referred for renal angiography because
the relationship between severe RAS and the presence of
clinical symptoms of PAD is not clear.
’ MATERIALS AND METHODS
All subjects included in the study had established hyper-
tension and suspicion of RAS based on clinical data. One or
more of the following conditions were considered: resistant
hypertension (sustained hypertension despite the use of
3 different classes of antihypertensive agents), previous hyper-
tensive pulmonary edema, congestive heart failure, malig-
nant hypertension or progressive renal failure. Subjects were
referred to the Hypertension Unit of the Heart Institute
(InCor) - Hospital das Clínicas da Faculdade de Medicina
da Universidade de São Paulo over a 2-year period. The
procedures were conducted in accordance with institutional
guidelines, and the institutional review committee approved
the protocol (1125/07 – Ethics Committee for Analysis of
Research Projects HC-FMUSP). All patients gave written
informed consent.
Patients were selected whose angiography would be use-
ful for the diagnosis of significant RAS and according to the
risk of RAS based on clinical data and additional diagnostic
noninvasive imaging that suggested the presence of RAS as
follows: decreased renal perfusion by renal scintigraphy,
increased renal blood flow velocity (X180 cm/s) observed
on Doppler ultrasound of the renal arteries, and/or magnetic
resonance angiography of renal arteries suggesting stenosis.
Patients with known PAD (prior ABIo0.9, peripheral lower
extremity vascular procedures, or major lower extremity
amputation) or RAS detected by prior renal angiography
were excluded.
Risk factors were measured at each clinical examination
and included age, resting blood pressure, smoking status,
presence of diabetes, and measurement of serum cholesterol
levels. Blood tests were performed to measure total choles-
terol, low-density lipoprotein cholesterol, high-density lipo-
protein cholesterol, and serum creatinine. The diagnosis of
hypercholesterolemia was based on whether the patients had
been prescribed cholesterol-lowering agents or had a fasting
total cholesterol level 4200 mg/dL. Patients were consid-
ered to have diabetes mellitus if dietary or pharmacological
interventions were required to maintain normal blood
glucose levels (o126 mg/dL) or if they were using specific
medications. Blood pressure (BP) was measured using an
automatic digital sphygmomanometer (OMRON-705CP, Japan)
after the patient had been in a resting position for 5 minutes.
The classification of BP was based on the average of 2 readings
taken by the examining physician and according to the recom-
mendations of the Eighth Joint National Committee on High
Blood Pressure (4).
Evaluation for the presence of IC was based on a struc-
tured history and questions from the Edinburgh Claudica-
tion Questionnaire (5). Patients with a positive questionnaire
(6 answers) were diagnosed as having IC. The clinical
evaluation also included the ABI measured with the patient
in the supine position after a 10-minute rest. A portable
vascular Doppler device (DV 610, Medmega, SP, Brazil) and
a mercury sphygmomanometer with an appropriate cuff size
for the patient’s arm circumference were used for measure-
ments. Systolic blood pressure measurements were performed
in the following order: right brachial artery, right dorsalis
pedis artery, right posterior tibial artery, left dorsalis pedis
artery, left posterior tibial artery, and right brachial artery.
The ABI was calculated for each lower limb to determine the
ratio between the highest ankle pressure (dorsalis pedis or
posterior tibial) and highest blood pressure (right or left arm)
(6). The lowest ABI value obtained was used for the analysis
of the results (right or left ABI).
Evaluation of renal arteries
All patients underwent renal angiography after a detailed
medical history and complete clinical examination were com-
pleted. For a statistical comparison of clinical and laboratory
variables, the study population was divided into 2 groups,
according to the presence (X70%) or absence (o70%) of
severe renal obstruction verified by renal angiography. Serum
creatinine levels were determined twice during the evalua-
tion, 1 day before the procedure and 3 days afterwards. The
glomerular filtration rate (GFR) was estimated with the
Modification of Diet in Renal Disease (MDRD) formula (7).
To prevent nephropathy induced by iodinated contrast, patients
who had an estimated GFR (eGFR) below 60 mL/min/m2
received a normal saline infusion (1 mL/kg/h) before and
24 h after the procedure plus 600 mg of oral N-acetyl-cysteine
twice daily and low-osmolar contrast for the procedure, as
previously described (8).
Statistical analysis
Data were analyzed using SPSS 20.0 statistical software.
Descriptive analysis was used to define the study population.
Parametric data are expressed as the mean± standard devia-
tion, and nonparametric data are expressed as the median
followed by the interquartile range or as percentages, when
appropriate. Student’s t test for independent samples and the
Mann-Whitney U test were used to compare quantitative
variables of groups with and without significant RAS. A Chi-
squared test was used to analyze qualitative variables, and
the Fisher correction was used when necessary. Univariate
and multiple logistic regression analyses were used to deter-
mine the factors associated with significant RAS in the entire
population. Variables with a value of po0.1 in the univariate
analysis were included in multivariate models. A p valueo0.05
was considered significant.
’ RESULTS
We evaluated 82 patients with clinical suspicion of RAS,
consisting of 62% females, with a mean age of 59±13 years.
The main characteristics of the total sample and groups
categorized by the presence or absence of severe RAS are
shown in Table 1. A high frequency of diabetes, IC, and
smoking were observed. Severe RAS diagnosed by renal
arteriography was present in 32 of 82 (39%) patients. The
prevalence of atherosclerosis risk factors was compared
between groups (RASo70% and RASX70%). Patients with
severe RAS were older (63±12 vs 56±12, p=0.006) and had a
greater prevalence of IC (55% vs 45%; p=0.027) and ABIo0.9
(44% vs 20%, p=0.021). No significant differences were observed
between the 2 groups concerning diabetes, smoking status,
angina, blood pressure, renal function, and dyslipidemia.
The average contrast volume used in renal arteriography
was 110 mL. Only 7 (8.5%) patients had a transient and
mild/moderate increase in creatinine levels suggestive of
contrast-induced nephropathy. Dialysis was not required,
and no patient developed serious complications during renal
arteriography. In the univariate analysis, the variables that
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were significantly correlated with the presence of severe
RAS included age, ABI, and IC (Table 2). In the multivariate
logistic regression analysis, the presence of IC was an inde-
pendent variable associated with severe RAS (OR: 3.33, 95%
CI: 1.03–10.82, p=0.04).
’ DISCUSSION
The present study produced the following important find-
ings: a) in patients with hypertension who were referred for
renal angiography under clinical suspicion of renovascular
hypertension, the frequencies of IC and an ABI o0.9 were
35% and 28%, respectively; and b) a validated clinical param-
eter (presence of IC defined by a standardized questionnaire)
was independently associated with severe RAS in patients
with hypertension. Atherosclerotic RAS is a clinical condition
frequently observed in patients with multiple cardiovascular
risk factors and concomitant atherosclerosis in other arterial
beds (10,11). Because atherosclerosis is a systemic disease,
it is conceivable that a significant proportion of patients with
hypertension who have confirmed RAS also have PAD;
however, current evidence is scant, even though PAD has a
high prevalence (12) and is associated with increased cardio-
vascular morbidity and mortality (13). Although IC is the
symptomatic expression of PAD, approximately 50% of
patients with IC remain asymptomatic (14). Conversely, we
found a high prevalence (35%) of IC among patients with
suspicion of RAS, and IC was more prevalent in the group
with RAS X70% than in the group without severe RAS
(55% vs 45%, p=0.027). IC has a significant effect on quality of
life and is strongly associated with impaired functional
capacity (15). In addition, IC is related to a twofold to
fourfold increased risk of mortality, predominantly from
cardiovascular disease (16), and its presence is a predictor of
higher rates of myocardial infarction, stroke, and disability in
older adults (17). Similar to the elevated prevalence of the
clinical presentation of IC, we found an elevated prevalence
of an ABI o0.9 (29%). This parameter was observed more
frequently in patients with severe RAS (44% vs 20%, p=0.021)
and is equally associated with an unfavorable prognosis as
described in previous studies (6,13,18).
The clinical expression of severity in the group with
RAS X70% can be verified by uncontrolled blood pressure
(SBP median=149 mmHg) despite patients’ use of 4 different
classes of antihypertensive medications (Table 1). The pre-
valence of diabetes mellitus in our study was 44%, which is
higher than that reported in other studies of patients with
PAD (between 20 and 29%) (19). The group with severe
RAS was older and possibly had more diffuse and serious
atherosclerosis, which could explain the higher prevalence
of PAD (20). We did not find studies that investigated the
prediction of RAS based on the presence of PAD defined by
clinical parameters or the ABI.
The main strength of the present investigation was the
systematic evaluation of IC symptoms and PAD in con-
secutive patients diagnosed according to the gold standard
method used for identifying RAS. We found a potential role
for IC symptoms, which can be easily identified when the
clinical history is obtained, for predicting severe RAS in high-
risk patients. This finding may reinforce the indication of
RAS investigation as important in patients with resistant
hypertension. Some limitations should also be addressed.
First, the sample size was small, which is primarily explained
by our single-center study design, and we only investigated
patients at high risk, suggesting the presence of RAS. Second,
the selection of patients with hypertension at high risk
for atherosclerotic RAS could overestimate the number of
individuals affected by atherosclerosis in other vessels,
including the peripheral arteries. However, both limitations
are related to the standard indications for investigating RAS
per se and could partially explain the high rate (35%) of IC in
selected patients despite of prevalence of severe RAS in the
total group.
Table 2 - Unadjusted and adjusted odds ratio variables in
patients according to severe renal artery stenosis (X70%).
Univariate Multivariate
Variables OR (CI) p value OR (CI) p value
Age 1.05 (1.01-1.10) 0.009 1.26 (0.97-1.08) 0.70
ABI 3.11 (1.16-1.01) 0.009 1.44 (0.37-5.66) 0.60
IC 2.85 (1.11-7.27) 0.029 3.33 (1.03-10.82) 0.04*
ABI: Ankle-brachial index; OR: odds ratio; CI: confidence interval;
IC: intermittent claudication.
*Adjusted for age, ABI, and IC.
Table 1 - Clinical characteristics of the 82 patients according to the presence of severe renal artery stenosis.
Variables Total (n=82) RAS (o70%) (n=50) RAS (X70%) (n=32) p value
Age, years 59±13 56±12 63±12 0.006*
Female, % 62 62 66 0.96
Mulatto, % 40 34 50 0.32
Diabetes mellitus, % 44 42 47 0.66
Smoking, % 32 30 34 0.68
Angina, % 26 28 22 0.55
IC, % 35 45 55 0.027*
SBP, mmHg 149±29 146±31 153±25 0.29
DBP, mmHg 78±12 77±13 80±11 0.18
Antihypertensives, n 4 (3-5) 5 (3.7-5) 4 (3-5) 0.18
Serum creatinine, mg/dL 1.4 (1.1-2.3) 1.38 (1.0-2.3) 1.51 (1.1-2.2) 0.49
eGFR o60 mL/min/m2, % 63 58 72 0.20
ABI o0.9, % 29 20 44 0.021*
LDL, mg/dL 110±35 107±32 113±40 0.46
HDL, mg/dL 40 (35-48) 41 (36-48) 36 (32-46) 0.09
Triglycerides, mg/dL 134 (95-178) 132 (98-171) 153 (91-202) 0.31
RAS: renal artery stenosis; IC: intermittent claudication; SBP: systolic blood pressure; DBP: diastolic blood pressure; eGFR: estimated glomerular filtration
rate; ABI: Ankle-brachial index; LDL: low-density lipoprotein cholesterol; HDL: high-density lipoprotein cholesterol.
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The presence of IC was independently associated with
severe RAS in patients suspected of having renovascular
hypertension based on clinical evidence.
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